Paper · 42979754
Coupling metabolic enhancement to plasmid spread enables programmable antimicrobial control.
Dorado-Morales P and 9 others. Nucleic Acids Res, 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Coupling metabolic enhancement to plasmid spread enables programmable antimicrobial control. Papers, record 42979754. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42979754
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Coupling metabolic enhancement to plasmid spread enables programmable antimicrobial control.
- Journal
- Nucleic Acids Res
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-11-06
Source PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Plasmids | Major topic |
| Conjugation, Genetic | |
| Salmonella enterica | |
| Anti-Bacterial Agents | |
| Shigella | |
| Drug Resistance, Multiple, Bacterial |
Source PubMed
Grants14
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| HORIZON-MSCA-2022-PF-01 CoKiP | European Commission | PubMed | ||
| 101104168 | European Commission | PubMed | ||
| ALTF 322-2022 | EMBO | PubMed | ||
| FDM202106013531 | Fondation pour la Recherche Médicale | PubMed | ||
| PCI2021-122062-2A | European Union NextGenerationEU/ PRTR | PubMed | ||
| 101086992-PLAS-FIGHTER | European Research Council | International | PubMed | |
| Institut Pasteur | PubMed | |||
| Centre National de la Recherche Scientifique | PubMed | |||
| EQU202103012569 | Fondation pour la Recherche Médicale Equipe FRM | PubMed | ||
| Pfizer Innovation France | PubMed |
1 to 10 of 14Source PubMed
See all 14 grantsTrials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References94
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35,410,999 | Impact of horizontal gene transfer on emergence and stability of cooperative virulence in Salmonella Typhimurium. | Nat Commun | 2022 | https://conductscience.org/library/papers/35410999 | PubMed |
| 2 | 19,302,791 | The naturally split Npu DnaE intein exhibits an extraordinarily high rate in the protein trans-splicing reaction. | FEBS Lett | 2009 | https://conductscience.org/library/papers/19302791 | PubMed |
| 3 | 18,824,123 | Bacteriophage lysins as effective antibacterials. | Curr Opin Microbiol | 2008 | https://conductscience.org/library/papers/18824123 | PubMed |
| 4 | 32,625,173 | Transcriptome Analysis of Zygotic Induction During Conjugative Transfer of Plasmid RP4. | Front Microbiol | 2020 | https://conductscience.org/library/papers/32625173 | PubMed |
| 5 | 25,547,794 | Two-component regulators control hilA expression by controlling fimZ and hilE expression within Salmonella enterica serovar Typhimurium. | Infect Immun | 2015 | https://conductscience.org/library/papers/25547794 | PubMed |
| 6 | 18,799,744 | HilD-mediated transcriptional cross-talk between SPI-1 and SPI-2. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18799744 | PubMed |
| 7 | 33,660,775 | Targeted-antibacterial-plasmids (TAPs) combining conjugation and CRISPR/Cas systems achieve strain-specific antibacterial activity. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/33660775 | PubMed |
| 8 | 18,482,767 | Bacterial conjugation-based antimicrobial agents. | Plasmid | 2008 | https://conductscience.org/library/papers/18482767 | PubMed |
| 9 | 34,567,840 | A highly effective and self-transmissible CRISPR antimicrobial for elimination of target plasmids without antibiotic selection. | PeerJ | 2021 | https://conductscience.org/library/papers/34567840 | PubMed |
| 10 | 35,648,146 | Anti-bacterial monoclonal antibodies: next generation therapy against superbugs. | Appl Microbiol Biotechnol | 2022 | https://conductscience.org/library/papers/35648146 | PubMed |
1 to 10 of 94
See all 94 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42979754
GET https://conductscience.org/api/papers/v1/42979754/references?page=2